NCT05127265 Pervasive Sensing and AI in Intelligent ICU
| NCT ID | NCT05127265 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Florida |
| Condition | Critical Illness |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2021-05-24 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2021-05-24 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Important information related to the visual assessment of patients, such as facial expressions, head and extremity movements, posture, and mobility are captured sporadically by overburdened nurses, or are not captured at all. Consequently, these important visual cues, although associated with critical indices such as physical functioning, pain, delirious state, and impending clinical deterioration, often cannot be incorporated into clinical status. The overall objectives of this project are to sense, quantify, and communicate patients' clinical conditions in an autonomous and precise manner, and develop a pervasive intelligent sensing system that combines deep learning algorithms with continuous data from inertial, color, and depth image sensors for autonomous visual assessment of critically ill patients. The central hypothesis is that deep learning models will be superior to existing acuity clinical scores by predicting acuity in a dynamic, precise, and interpretable manner, using autonomous assessment of pain, emotional distress, and physical function, together with clinical and physiologic data.
Eligibility Criteria
Inclusion Criteria: * aged 18 or older * admitted to UF Health Shands Gainesville ICU ward * expected to remain in ICU ward for at least 24 hours at time of screening Exclusion Criteria: * under the age of 18 * on any contact/isolation precautions * expected to transfer or discharge from the ICU in 24 hours or less * unable to provide self-consent or has no available proxy/LAR
Contact & Investigator
Azra Bihorac, MD, MS
PRINCIPAL INVESTIGATOR
University of Florida
Frequently Asked Questions
Who can join the NCT05127265 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Critical Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05127265 currently recruiting?
Yes, NCT05127265 is actively recruiting participants. Contact the research team at adavidson@ufl.edu for enrollment information.
Where is the NCT05127265 trial being conducted?
This trial is being conducted at Gainesville, United States.
Who is sponsoring the NCT05127265 clinical trial?
NCT05127265 is sponsored by University of Florida. The principal investigator is Azra Bihorac, MD, MS at University of Florida. The trial plans to enroll 400 participants.